Paper6440451
Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
Meares CF and 5 others. Anal Biochem, 1984. Cited by 359 papers, by iCite.
Cite this record
ConductScience Library. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Papers, record 6440451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6440451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Chelating Agents | Major topic |
| Cross-Linking Reagents | Major topic |
| Metals | Major topic |
| Animals | |
| Antibody Affinity | |
| B-Lymphocytes | |
| Chromatography, High Pressure Liquid | |
| Chromatography, Thin Layer | |
| Cobalt Radioisotopes | |
| Edetic Acid | |
| Indium | |
| Lymph Nodes | |
| Magnetic Resonance Spectroscopy | |
| Mice | |
| Mice, Inbred BALB C | |
| Protein Binding | |
| Radioisotopes | |
| Spectrophotometry, Infrared | |
| Spectrophotometry, Ultraviolet |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA00462 | NCI NIH HHS | United States | K04CA000462 | PubMed and NIH | NIH RePORTER |
| CA16861 | NCI NIH HHS | United States | R01CA016861 | PubMed and NIH | NIH RePORTER |
| CA18343 | NCI NIH HHS | United States | PubMed | PubMed | |
| R37CA016861 | NIH | NIH RePORTER |
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 359 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42325638 | Side-by-Side Comparison of Different Thiol Bioconjugation Strategies for the Chemoselective Radiolabeling of Human Serum Albumin with Zirconium-89. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42325638 | PubMed |
| 41941715 | Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity. | J Med Chem | 2026 | https://conductscience.org/library/papers/41941715 | PubMed |
| 41872337 | A phase I study to evaluate the dosimetry and safety of [89Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41872337 | PubMed |
| 40881666 | Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin‑1 in Cancer. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40881666 | PubMed |
| 40208951 | Development of Galectin-7-Specific Nanobodies: Implications for Immunotherapy and Molecular Imaging in Cancer. | J Med Chem | 2025 | https://conductscience.org/library/papers/40208951 | PubMed |
| 39667814 | Antibody-Based PET Imaging of Misfolded Superoxide Dismutase 1 in an Amyotrophic Lateral Sclerosis Mouse Model. | J Nucl Med | 2025 | https://conductscience.org/library/papers/39667814 | PubMed |
| 39174789 | Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. | Mol Imaging Biol | 2024 | https://conductscience.org/library/papers/39174789 | PubMed |
| 39065579 | Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39065579 | PubMed |
| 38675440 | Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38675440 | PubMed |
| 38376808 | Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer. | Eur J Nucl Med Mol Imaging | 2024 | https://conductscience.org/library/papers/38376808 | PubMed |
| 38366964 | A Kinetically Controlled Bioconjugation Method for the Synthesis of Radioimmunoconjugates and the Development of a Domain Mapping MS-Workflow for Its Characterization. | Bioconjug Chem | 2024 | https://conductscience.org/library/papers/38366964 | PubMed |
| 37552575 | Evaluation of [89Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer. | Mol Pharm | 2023 | https://conductscience.org/library/papers/37552575 | PubMed |
| 34959652 | Humanization, Radiolabeling and Biodistribution Studies of an IgG1-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34959652 | PubMed |
| 34298682 | A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298682 | PubMed |
| 34014767 | In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab. | Cancer Biother Radiopharm | 2021 | https://conductscience.org/library/papers/34014767 | PubMed |
| 33574346 | Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT. | Sci Rep | 2021 | https://conductscience.org/library/papers/33574346 | PubMed |
| 33537102 | Abraxane-induced bone marrow CD11b+ myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with 64Cu-labeled anti-CD11b and prevented by anti-CSF-1. | Theranostics | 2021 | https://conductscience.org/library/papers/33537102 | PubMed |
| 32123103 | Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32123103 | PubMed |
| 31044647 | Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab. | Mol Imaging | 2019 | https://conductscience.org/library/papers/31044647 | PubMed |
| 31015228 | Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma. | Cancer Res | 2019 | https://conductscience.org/library/papers/31015228 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6440451
GET https://conductscience.org/api/papers/v1/6440451/cited_by?page=2